Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News World leading cancer trials in Birmingham get £10 million boost Adults and children with cancer will continue to benefit from world-class clinical trials led by the University of Birmingham
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
12 September 2023 Round of Successful Grant Applications for the Institute of Cancer and Genomic Sciences Professor Jo Parish, Professor Aga Gambus and Dr Clare Davies have been successful in securing over one million pounds in grant applications.
11 September 2023 New Appointments: Professor Guy Pratt This Summer we welcomed Professor Guy Pratt to the Institute of Cancer and Genomics.
25 July 2023 ICGS has three new Professors The Institute of Cancer and Genomic Sciences has three new Professors: Eva Petermann, Aga Gambus and Simon Bach.
25 July 2023 Vaccine rollout cut Covid deaths for cancer patients by 84% New two year UK-wide study finds Covid-19 risk for cancer patients still higher than general population, but fell following availability of vaccinations in 2021
06 July 2023 Many clinically at-risk patients mounted low or no immune response to Covid vaccines OCTAVE study reveals real-world vaccine response in patients with impaired immune systems
21 June 2023 Genetic mutations blunt immune defences in leukaemia-linked rare bone marrow disorder Zebrafish used to identify bone marrow failures in GATA2 deficiency that result in defective DNA repair and marrow failure